These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28714367)

  • 1. PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.
    Li J; Dou D; Li P; Luo W; Lv W; Zhang C; Song X; Yang Y; Zhang Y; Xu Y; Xiao F; Wei Y; Qin J; Li H; Yang X
    Tumour Biol; 2017 Jul; 39(7):1010428317706914. PubMed ID: 28714367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of MCM6 on hepatocellular carcinoma in a Southern Chinese Zhuang population.
    Jia W; Xie L; Wang X; Zhang Q; Wei B; Li H; Qin S; Chen S; Liu J; Tan Y; Zheng S; Liang X; Yang X
    Biomed Pharmacother; 2020 Jul; 127():110171. PubMed ID: 32403044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Fra-1 in human hepatocellular carcinoma and its prognostic significance.
    Gao XQ; Ge YS; Shu QH; Ma HX
    Tumour Biol; 2017 Jun; 39(6):1010428317709635. PubMed ID: 28653890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma.
    Taniguchi T; Kishi K; Nakagawa T; Tanaka H; Tanaka T; Tomonari T; Okamoto K; Sogabe M; Miyamoto H; Okahisa T; Muguruma N; Kajimoto M; Sagawa I; Takayama T
    Digestion; 2017; 95(3):242-251. PubMed ID: 28384634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma.
    Liu T; Kan XF; Ma C; Chen LL; Cheng TT; Zou ZW; Li Y; Cao FJ; Zhang WJ; Yao J; Li PD
    Tumour Biol; 2017 Jun; 39(6):1010428317700410. PubMed ID: 28635398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression signature of lysosomal-associated transmembrane protein 4B in hepatitis C virus-induced hepatocellular carcinoma.
    Roy G; Roy P; Bhattacharjee A; Shahid M; Misbah M; Gupta S; Husain M
    Int J Biol Markers; 2018 Aug; 33(3):283-292. PubMed ID: 29882487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
    Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
    Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma.
    Cao J; Hou P; Chen J; Wang P; Wang W; Liu W; Liu C; He X
    Tumour Biol; 2017 Jun; 39(6):1010428317705753. PubMed ID: 28631558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy.
    Tang J; Ou J; Xu C; Yi C; Xue F; Xu L; Lai F; Tang J; Li S; Kang T; Ding W; Wang B
    Oncol Rep; 2017 Oct; 38(4):2251-2258. PubMed ID: 28765910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEP domain containing 1 is a novel diagnostic marker and prognostic predictor for hepatocellular carcinoma.
    Yuan SG; Liao WJ; Yang JJ; Huang GJ; Huang ZQ
    Asian Pac J Cancer Prev; 2014; 15(24):10917-22. PubMed ID: 25605201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
    Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
    Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.
    Pan L; Yao M; Zheng W; Gu J; Yang X; Qiu L; Cai Y; Wu W; Yao D
    Tumour Biol; 2016 Apr; 37(4):5561-8. PubMed ID: 26577850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
    Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
    Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
    Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma.
    Liu XF; Thin KZ; Ming XL; Shuo-Li ; Ping-Luo ; Man-Zhu ; Li ND; Tu JC
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818794494. PubMed ID: 30126319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes.
    Pu M; Wang J; Huang Q; Zhao G; Xia C; Shang R; Zhang Z; Bian Z; Yang X; Tao K
    Tumour Biol; 2017 Jul; 39(7):1010428317709127. PubMed ID: 28714366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.